Skip to content
WriteVoice WriteVoice Start Creating

167 ADHD Statistics October 2026

Updated 167 primary-source citations Refreshed monthly

On this page
  1. Key Takeaways
  2. How many children and adults have ADHD?
  3. Are ADHD diagnosis rates rising?
  4. How is ADHD treated, and is the ADHD medication shortage over?
  5. How does ADHD affect school and written work?
  6. How does adult ADHD affect work and productivity?
  7. What accommodations and assistive tools help people with ADHD?
  8. Methodology and Sources

ADHD statistics now describe adults as much as children. An estimated 7 million US children aged 3 to 17, or 11.7%, had a current ADHD diagnosis in 2024, according to HRSA's National Survey of Children's Health, a national survey of parents, as reported by CDC (CDC, Data on ADHD in Children (HRSA NSCH data), Jul 2026). Most children with ADHD do not simply grow out of it: across 20 World Health Organization surveys, 57.0% of adults who had ADHD as children still had it when interviewed (Attention Deficit and Hyperactivity Disorders, Fayyad et al., Nov 2016).

Diagnosis rates have climbed for 25 years. Whether ADHD itself has become more common is a separate question: a meta-regression of 135 studies across three decades found no rise in the share of children who meet ADHD criteria when standardized diagnostic procedures are used (International Journal of Epidemiology, Polanczyk et al., Jan 2014). That points to better recognition, and care, school support and workplace support have not kept pace with it.

Every number links to the study, survey or agency that produced it, with the date of its data. Parent surveys, clinical interviews, health records and global models count different things, so each figure says which one it is.

Key Takeaways

How many children and adults have ADHD?

Many children with ADHD still have it as adults. US surveys now count more than twice as many adults with a current diagnosis as children, and the adult ADHD statistics below show a wide gap between who has ADHD and who has been told. How big the number looks depends on what is counted, so each figure names its method.

ADHD statistics: 15.5 million US adults (6%) currently have ADHD, nearly 1 in 3 adults with ADHD take stimulant medication and almost half have used telehealth for ADHD care, NCHS Rapid Surveys System, October to November 2023
Figure 1: CDC's summary of its national survey of adult ADHD diagnosis shows how large the adult group has become, and how much of its care already runs through stimulant prescriptions and telehealth. Source: CDC, Data on ADHD in Adults (NCHS Rapid Surveys System, Oct-Nov 2023), Jun 2026. Screenshot of the source page, captured 2 Oct 2026.

How many US children have ADHD?

Between one in ten and one in eight US children aged 3 to 17 have an ADHD diagnosis, depending on the survey year and whether parents were asked about a current or a past diagnosis. Diagnosis rises with age and varies by sex, race, region and state.

Most children with ADHD also have at least one other diagnosed condition.

How common is ADHD in adults?

It depends on the method. Clinical interviews, self-reported diagnoses and health records give different answers, and health records give the lowest, because many adults with ADHD have never been diagnosed.

  • Adult ADHD is concentrated in younger adults: 84.5% of US adults with a current diagnosis were under 50, against 51.2% of adults never diagnosed (CDC MMWR, Oct 2024).
  • The sex gap narrows in adulthood: men make up 55.8% of US adults with a current ADHD diagnosis and women 44.2% (CDC MMWR, Oct 2024).
  • In clinical follow-up interviews from the National Comorbidity Survey Replication (2001-2003), 4.4% of US adults aged 18 to 44 had current ADHD, an estimate that predates the recent rise in adult diagnosis (American Journal of Psychiatry, Kessler et al., Apr 2006).
  • In the same clinical survey, adult ADHD was more common in men (5.4%) than in women (3.2%) (American Journal of Psychiatry, Kessler et al., Apr 2006).
  • Among US adolescents aged 13 to 18, lifetime ADHD prevalence was 8.7% in diagnostic interviews, with boys (13.0%) three times as likely as girls (4.2%) to be affected (Journal of the American Academy of Child and Adolescent Psychiatry, Merikangas et al., Oct 2010).
  • Clinician-recorded adult ADHD diagnoses in Kaiser Permanente Northern California more than doubled in a decade, from 0.43% of adult members in 2007 to 0.96% in 2016, far below survey estimates of how many adults have ADHD (JAMA Network Open, Chung et al., Nov 2019).

How common is ADHD worldwide?

Pooling 175 studies, about 7.2% of children worldwide meet the diagnostic criteria for ADHD (Pediatrics, Thomas et al., Mar 2015). Adult estimates run from under 3% to almost 7%, depending on whether a study counts ADHD that began in childhood or any adult with symptoms.

  • A meta-analysis of 41 community studies in 27 countries put the worldwide prevalence of ADHD in children and adolescents at 3.4%, using probability samples and standardized assessments (Journal of Child Psychology and Psychiatry, Polanczyk et al., Feb 2015).
  • An umbrella review of 13 meta-analyses covering 588 studies and 3.3 million participants put global ADHD prevalence in children and adolescents at 8.0%, twice as high in boys (10%) as in girls (5%) (Journal of Affective Disorders, Ayano et al., Jul 2023).
  • Worldwide, 2.58% of adults have persistent ADHD that began in childhood and 6.76% have symptomatic ADHD regardless of when it began, about 139.84 million and 366.33 million adults in 2020 (Journal of Global Health, Song et al., Feb 2021).
  • An umbrella review of five meta-analyses covering 57 studies and more than 21 million adults put the pooled prevalence of adult ADHD at 3.10% (Psychiatry Research, Ayano et al., Sep 2023).
  • In WHO World Mental Health surveys of 26,744 adults, current adult ADHD averaged 2.8%, rising to 3.6% in high-income countries and falling to 1.4% in low- and lower-middle-income countries (Attention Deficit and Hyperactivity Disorders, Fayyad et al., Nov 2016).
  • The Global Burden of Disease 2021 study estimated that 46.9 million people under 20 had ADHD worldwide in 2021, a prevalence of 1.78%, and the authors note the figures may be underestimates because of the model's methods (Molecular Psychiatry, Cortese et al., Jun 2026).
  • In the same estimates, ADHD prevalence under age 20 in high-income North America rose 12.88% between 1990 and 2021 to 3,627 per 100,000 young people, while the global rate fell 6% (Molecular Psychiatry, Cortese et al., Jun 2026).

Are ADHD diagnosis rates rising?

Yes, in every national survey, with the steepest stretch after 2020. The growth sits mostly with adults and privately insured families, which points to recognition catching up.

Percent of US children aged 3 to 17 with a parent-reported ADHD diagnosis, NHIS 1997 to 2024 and NSCH 2003 to 2024, rising from 5.5% in 1997 to 12.0% (NHIS) and 12.6% (NSCH) in 2024
Figure 2: Every series on the chart rises, across two federal surveys and their redesigns, and the sharpest climb in both comes after 2020. Source: CDC, Trends in ADHD Among U.S. Children (NCHS NHIS and HRSA NSCH data), Jul 2026. Screenshot of the source page, captured 2 Oct 2026.

How have childhood ADHD diagnosis rates changed since 1997?

They have risen in every national survey since the late 1990s and in every age, sex, race, income and regional group studied. CDC warns that different versions of the same survey should not be compared directly, so each series below stands on its own.

  • In the National Health Interview Survey, the share of US children aged 3 to 17 ever diagnosed with ADHD rose from 5.5% in 1997 to 9.8% in 2018, the last year before the survey was redesigned (CDC, Trends in ADHD Among U.S. Children, Jul 2026).
  • Under the redesigned survey, the share of children ever diagnosed with ADHD rose from 8.8% in 2019 to 12.0% in both 2023 and 2024 (CDC, Trends in ADHD Among U.S. Children, Jul 2026).
  • In the National Survey of Children's Health, parent-reported ever-diagnosis rose from 7.2% in 2003 to 10.4% in 2011 and, after the survey's 2016 redesign, from 9.7% in 2016 to 12.6% in 2024 (CDC, Trends in ADHD Among U.S. Children, Jul 2026).
  • A parent-reported history of ADHD diagnosis rose 42% between 2003 and 2011, when 11% of US children aged 4 to 17, or 6.4 million, had ever been diagnosed (Journal of the American Academy of Child and Adolescent Psychiatry, Visser et al., Nov 2013).
  • Across 20 years of survey data, diagnosed ADHD among US children and adolescents aged 4 to 17 rose from 6.1% in 1997-1998 to 10.2% in 2015-2016, and the increase showed up in every subgroup by age, sex, race and ethnicity, income and region (JAMA Network Open, Xu et al., Aug 2018).
  • Between 2009-2011 and 2015-2017, ADHD prevalence among US children aged 3 to 17 rose from 8.5% to 9.5%, while autism more than doubled from 1.1% to 2.5% (Pediatrics, Zablotsky et al., Oct 2019).

Why are more adults being diagnosed with ADHD?

Many adults with ADHD were missed as children and are being diagnosed now. New adult diagnoses keep climbing in health-system records, and the growth since 2021 sits in people over 30.

  • In Kaiser Permanente Northern California records covering 5.3 million adults, the incidence of new adult ADHD diagnoses rose from 9.43 to 13.49 per 10,000 person-years between 2007 and 2016 (JAMA Network Open, Chung et al., Nov 2019).
  • In Truveta's US health-system data, the monthly rate of first-time ADHD diagnoses rose 27%, from 6.3 to 8.0 per 10,000 eligible people, between January 2021 and October 2024; Truveta labels these preliminary findings, not peer reviewed (Truveta Research, Dec 2024).
  • The rise in Truveta's data came from people over 30: no age group under 30 saw an increase, and by 2024 30- to 44-year-olds made up 30.7% of first-time diagnoses, the largest share of any adult age group, taking over from 18- to 29-year-olds, who led in 2018 with 27.7% (Truveta Research, Dec 2024).
  • In UK primary care records from 2000 to 2018, the relative rise in ADHD was largest among adults: diagnoses among men aged 18 to 29 rose about 20-fold and ADHD prescriptions nearly 50-fold (BJPsych Open, McKechnie et al., Jul 2023).
  • Demand has outrun NHS capacity in England, where waits for ADHD services now reach more than 4 years for children and more than 8 years for adults (NHS England, Report of the independent ADHD Taskforce: Part 1, Jun 2025).

Who is diagnosed, and who gets missed?

Who gets diagnosed depends on access to care as well as on symptoms. Boys and publicly insured children are diagnosed most, but since 2016 the growth has come from privately insured, White, Asian and multiracial children. Black and Hispanic children are diagnosed less often than White children with similar behavior, and girls later than boys.

  • Since 2016, diagnosis growth has been concentrated among privately insured children: current ADHD diagnosis rose from 6.8% in 2016-17 to 9.3% in 2022-23 for children with private insurance only, against 12.4% to 13.5% for children with any public insurance (Journal of Clinical Child and Adolescent Psychology, Katz et al., Feb 2026).
  • Between 2016-17 and 2022-23, ADHD diagnosis rose significantly only among Asian (prevalence ratio 1.59), White (1.29) and multiracial (1.22) children, and not among Black children (Journal of Clinical Child and Adolescent Psychology, Katz et al., Feb 2026).
  • Diagnosis grew faster among girls than boys over the same period, with prevalence ratios of 1.33 for girls and 1.14 for boys, though the difference between the two did not reach statistical significance (Journal of Clinical Child and Adolescent Psychology, Katz et al., Feb 2026).
  • Following a national kindergarten cohort through eighth grade (1998 to 2007), researchers found that, with confounders controlled, Black children had 69% lower odds and Hispanic children 50% lower odds of an ADHD diagnosis than White children (Pediatrics, Morgan et al., Jul 2013).
  • Among adults, the gap by race persists in health records: from 2007 to 2016, diagnosed ADHD prevalence ranged from 0.67% to 1.42% among White adults, against 0.22% to 0.69% among Black adults, 0.25% to 0.65% among Hispanic adults and 0.11% to 0.35% among Asian American adults (JAMA Network Open, Chung et al., Nov 2019).
  • Black adults make up 7.4% of US adults with a current ADHD diagnosis but 12.9% of adults who have never been diagnosed, while White adults make up 70.4% and 61.4% (CDC MMWR, Oct 2024).
  • By 2018, 255 per 10,000 boys and 67.7 per 10,000 girls in UK primary care had an ADHD diagnosis, and 74.3 per 10,000 men against 20 per 10,000 women (BJPsych Open, McKechnie et al., Jul 2023).
  • In a Danish register of 1.3 million children, ADHD diagnoses peaked at age 8 in boys but not until age 17 in girls, which the authors read as possible delayed detection (JAMA Psychiatry, Dalsgaard et al., Feb 2020).
  • In 2011, the median US child with current ADHD had been diagnosed at 6.2 years of age, ranging from 4.4 years for children with severe ADHD to 7.0 years for mild cases (Journal of the American Academy of Child and Adolescent Psychiatry, Visser et al., Nov 2013).

How is ADHD treated, and is the ADHD medication shortage over?

Diagnosis grew faster than care. A smaller share of diagnosed children take medication than in 2016, adults diagnosed late often get no treatment at all, and the stimulant shortage is not over.

Percent of US children aged 3 to 17 with current ADHD taking ADHD medication or receiving behavioral treatment, NSCH 2003 to 2024
Figure 3: Since the parent survey was redesigned in 2016, the share of children with current ADHD taking medication drifted down to a 2023 low before a small 2024 uptick, while behavioral treatment never reached half of diagnosed children. Source: CDC, Trends in ADHD Among U.S. Children (HRSA NSCH data), Jul 2026. Screenshot of the source page, captured 2 Oct 2026.

How many people with ADHD get treatment?

Most children and adults with a diagnosis get some treatment, but a large minority get none, and the share of diagnosed children in treatment has fallen since 2016. Two analyses of the same parent survey use different methods, so their medication figures differ and are listed separately.

  • Across states, the share of children with current ADHD receiving any ADHD treatment ranged from 58% to 80% in 2020 to 2023, and the share taking medication ranged from 38% to 72% (CDC, Data on ADHD in Children, Jul 2026).
  • In 2024, 53.2% of US children aged 3 to 17 with current ADHD were taking ADHD medication and 46.1% had received behavioral treatment in the past year, on CDC's National Survey of Children's Health trend series (CDC, Trends in ADHD Among U.S. Children, Jul 2026).
  • The share of diagnosed children receiving any ADHD treatment fell from 76.9% in 2016 to 70.8% in 2023, even as diagnosis rose (Journal of Clinical Child and Adolescent Psychology, Katz et al., Feb 2026).
  • In that analysis, medication use among children with ADHD dropped from 62.5% to 53.0% between 2016 and 2023, while behavioral treatment held steady at 47.3% and 48.2% (Journal of Clinical Child and Adolescent Psychology, Katz et al., Feb 2026).
  • The fall in medication use was concentrated in boys: 65.8% of boys with ADHD took medication in 2016-17 against 53.3% in 2022-23, while girls went from 57.3% to 53.4%, a change that was not statistically significant (Journal of Clinical Child and Adolescent Psychology, Katz et al., Feb 2026).
  • Among US adults with current ADHD, 36.5% received no treatment at all in the previous year, and 35.2% received both medication and counseling or behavioral treatment (CDC MMWR, Oct 2024).
  • 46.0% of adults with current ADHD have used telehealth for their ADHD care, and 8.9% were diagnosed through telehealth visits alone (CDC MMWR, Oct 2024).
  • Family doctors are the most common source of ADHD care for privately insured adults: 31.9% had an ADHD visit with a family practice physician in 2021, 25.7% with a psychiatrist and 17.1% with a nurse practitioner or psychiatric nurse; among Medicaid enrollees, nurse practitioners and psychiatric nurses saw 29.1% (Journal of Attention Disorders, Danielson et al., Mar 2024).
  • In insurance claims, more than half of adults receiving ADHD care in 2021 had at least one ADHD visit by telehealth: 52.6% of privately insured adults and 51.6% of Medicaid enrollees (Journal of Attention Disorders, Danielson et al., Mar 2024).

How has stimulant prescribing changed?

Stimulant prescribing to adults, and especially to women, rose sharply after 2020. Since 2025 the DEA has raised production quotas for lisdexamfetamine, d-amphetamine and methylphenidate.

  • The share of commercially insured Americans aged 5 to 64 with at least one stimulant prescription fill rose from 3.6% in 2016 to 4.1% in 2021 (CDC MMWR, Mar 2023).
  • From 2020 to 2021 alone, the share of women with stimulant fills rose by between 14.3% and 19.2% (annual percent change) in the 15 to 44 and 50 to 54 age groups, and the share of men by between 11.1% and 14.7% in the 25 to 44 and 50 to 54 age groups (CDC MMWR, Mar 2023).
  • New Schedule II stimulant prescriptions for patients aged 20 to 39 rose 30%, from 1,887,017 to 2,455,706, between the period before the COVID-19 pandemic and the period during it (April 2018 to March 2022), in an FDA analysis of national pharmacy data (JAMA Psychiatry, Chai et al., Jan 2024).
  • New stimulant prescriptions for female patients rose 25% over the same comparison, and new nonstimulant ADHD prescriptions for patients aged 20 to 39 rose 81% (JAMA Psychiatry, Chai et al., Jan 2024).
  • The DEA raised its 2025 production quota for lisdexamfetamine by 22%, from 32,736,000 to 39,907,536 grams, citing rising global demand after the drug was approved for ADHD in 29 countries besides the US (DEA, Federal Register, Sep 2025).
  • For 2026, the DEA set the lisdexamfetamine quota at 51,290,743 grams, 28.5% above the raised 2025 level (DEA, Federal Register, Jan 2026).
  • In October 2025 the DEA raised the 2025 quota for d-amphetamine (for sale) by 25%, from 21,200,000 to 26,450,000 grams, and for methylphenidate (for sale) by 9%, from 53,283,000 to 58,283,000 grams, while stating that the existing quotas were adequate for medical demand and the increase was for product development (DEA, Federal Register, Oct 2025).
  • The DEA projects global consumption of d-amphetamine products to grow 15.16% and methylphenidate products 7.59% in 2025 over 2024 (DEA, Federal Register, Oct 2025).

What caused the ADHD medication shortage, and is it over?

No, it is not over. Generic Vyvanse and extended-release methylphenidate are listed in shortage alongside generic Adderall, and research points to a 2022 collapse in imported amphetamine ingredient as the trigger, with DEA quotas left partly unused.

  • Of the 73 mixed amphetamine salts tablet presentations listed by 11 manufacturers, 19 were unavailable and 9 had limited availability, with manufacturers most often citing a shortage of the active ingredient (FDA Drug Shortages, Oct 2026).
  • Lisdexamfetamine capsules (generic Vyvanse) have been listed in shortage since 14 July 2023 and were still current, with 33 of 90 listed presentations in limited supply (FDA Drug Shortages, Oct 2026).
  • Extended-release methylphenidate tablets have been listed in shortage since 26 July 2023 and were still current (FDA Drug Shortages, Oct 2026).
  • About a third of US adults with ADHD (33.4%) took a prescription stimulant in the past year, the group the shortage hits directly (CDC MMWR, Oct 2024).
  • US imports of raw amphetamine fell by more than a third in 2022, from 13,920 kg in 2021 to 8,685 kg, and Germany supplied more than 85% of those imports over the past decade (JAMA Health Forum, Currie and Malinovskaya, Mar 2026).
  • DEA quotas were not the binding limit in 2022: manufacturers were allotted 38,418 kg of amphetamine out of a 42,400 kg aggregate quota, and retail distribution reached only about 70% of the allotted amount (JAMA Health Forum, Currie and Malinovskaya, Mar 2026).
  • The shortage raised costs for Medicaid: spending per enrollee on immediate-release amphetamine products rose 7% between the second quarter of 2022 and the first quarter of 2023 even as prescriptions fell, and generic immediate-release prices rose 6% (Health Affairs Scholar, Yu et al., May 2026).
  • In a survey of 438 students with a stimulant prescription at six US universities, 64.6% had trouble getting their medication in the 2024-25 academic year (Journal of Adolescent Health, Schepis et al., Mar 2026).
  • Among those students, about 74% said the shortage made coursework harder to complete, and more than 40% reported poorer grades (Journal of Adolescent Health, Schepis et al., Mar 2026).
  • About 72% of K-12 public school teachers who knew their students' medication status had a student stop ADHD medication in the 2022-23 school year because they could not get it (Journal of the American Academy of Child and Adolescent Psychiatry, Stein et al., Sep 2025).

How does ADHD affect school and written work?

ADHD's academic cost shows up most clearly in writing, and it outlasts school. Medication is linked to better test scores, but children treated for ADHD still leave school earlier and with lower grades than their peers.

Bar chart of US students aged 3 to 21 served under IDEA by disability type in school year 2022-23: specific learning disability about 32%, speech or language impairment about 19%, other health impairment, the category that includes ADHD, about 15%, autism about 13%, developmental delay about 7%, intellectual disability about 6%, emotional disturbance about 4%
Figure 4: Other health impairment, the special education category federal rules use for ADHD, is now the third-largest group of students served under IDEA, behind only learning disabilities and speech or language impairments. Data cover students aged 3 to 21 in school year 2022-23. Source: National Center for Education Statistics (NCES), Condition of Education, Students With Disabilities, May 2024. Screenshot of the source's chart, captured 2 Oct 2026.

How many students get special education or 504 support for ADHD?

Schools do not count ADHD as its own category. Students with ADHD who get support are counted under IDEA's other health impairment category or under a Section 504 plan, and the national counts below cover all disabilities.

How does ADHD affect writing and grades?

Writing is where the gap is widest, and it shows up even in children with no reading disability. Reading, test scores and grades lag too, and treatment is linked to better test scores more often than to better grades.

  • Children with ADHD had 6.6 times (boys) and 7.4 times (girls) the risk of developing a written-language disorder without any reading disability, in a Mayo Clinic birth cohort of 5,718 children (Pediatrics, Yoshimasu et al., Sep 2011).
  • In the same cohort, 51% of boys and 46.7% of girls with ADHD met criteria for a reading disability by 19, compared with 14.5% and 7.7% of children without ADHD (Pediatrics, Yoshimasu et al., Sep 2010).
  • 36.5% of US children with ADHD also had a learning disability in 2022, according to a national parent survey (CDC, Data on ADHD in Children, Jul 2026).
  • 14.8% of US children with ADHD also had a speech or language disorder in 2022 (CDC, Data on ADHD in Children, Jul 2026).
  • At about age 13, the median reading score of children with ADHD sat at the 45th national percentile, against the 73rd for classmates without ADHD, and they were three times more likely to repeat a grade (Journal of Developmental and Behavioral Pediatrics, Barbaresi et al., Aug 2007).
  • Across 766,244 Scottish schoolchildren, those receiving ADHD medication had 8.6 times the odds of a recorded special educational need (JAMA Pediatrics, Fleming et al., May 2017).
  • Even while on medication, children treated for ADHD in Scotland had 3.35 times the odds of low academic attainment compared with their peers (JAMA Pediatrics, Fleming et al., May 2017).
  • Children treated for ADHD were excluded from school at 5.8 times the rate of their classmates, after adjusting for social, birth and co-occurring conditions (JAMA Pediatrics, Fleming et al., May 2017).
  • In a review of 176 long-term studies co-authored by employees of Shire, an ADHD drug maker, treatment was linked to better achievement test scores in 79% of outcomes but to better school performance, such as grades and grade retention, in only 42% (Journal of Attention Disorders, Arnold et al., Jan 2015).

Reading disability overlaps heavily with ADHD, and the dyslexia hub covers it in depth. Writing asks a student to hold an idea, organize it and type it at the same time. Speaking a first draft removes the typing step, which is the idea behind voice to text for ADHD. It is a writing aid, not a treatment, and the evidence on dictation for writing difficulties is summarized in the last section.

How do students with ADHD fare after high school?

Fewer finish school, fewer enroll in four-year colleges and fewer graduate from them. Stimulant treatment has not been shown to close the dropout gap.

How does adult ADHD affect work and productivity?

Lost work is the largest economic cost of ADHD, larger than treatment. Most of that loss happens while people are at their desks: workers with ADHD lose more days to getting less done, or doing it less well, than to staying home.

Table of annual excess days of lost work performance among employed adults aged 18 to 44 with ADHD in 10 countries, split into days absent, reduced quantity of work and reduced quality of work, WHO World Mental Health Surveys
Figure 5: Across 10 countries, workers with ADHD lose far more days to doing less, or doing it less well, at work than to staying home, and the US carries one of the two largest totals. Source: Occupational and Environmental Medicine, de Graaf et al., The prevalence and effects of adult ADHD on the performance of workers (WHO World Mental Health Survey Initiative), Table 4, May 2008. Screenshot of the source page, captured 2 Oct 2026.

How much work time does ADHD cost?

Several weeks of work performance a year, in the largest surveys, and most of it is time at work when less gets done rather than days off. The big national studies date from the 2000s and have not been repeated at that scale.

How does ADHD affect employment and earnings?

Childhood ADHD is linked to lower employment, lower earnings and more time on benefits in US, Swedish, Scottish and Norwegian data. Whether medication changes that is unsettled: studies point both ways.

  • In a sibling-comparison study of US young adults, childhood ADHD raised the chance of receiving social assistance by 15 percentage points, gaps the study calls larger than many estimates of the Black-White and gender earnings gaps (Health Economics, Fletcher, Feb 2014).
  • By their late 20s, 61% of young adults with childhood ADHD had been fired from a job, against 43% of peers, and 33% had been laid off, against 13% (Journal of Abnormal Child Psychology, Kuriyan et al., Jan 2013).
  • At ages 23 to 32, young adults with childhood ADHD were 11 times more likely than peers to be neither working nor in school (Journal of Abnormal Child Psychology, Kuriyan et al., Jan 2013).
  • In a US community survey, 52% of adults diagnosed with ADHD were employed, against 72% of matched adults, and they had changed jobs 5.4 times in 10 years, against 3.4 (The Journal of Clinical Psychiatry, Biederman et al., Apr 2006).
  • In Sweden, people with ADHD earned 17% less a year than peers and spent 12.19 more days a year unemployed, across 1.2 million school leavers followed for 6 to 16 years (PLoS One, Jangmo et al., Mar 2021).
  • The same Swedes with ADHD were 19 times as likely to receive a disability pension (odds ratio 19.0), a gap mostly explained by co-occurring intellectual disability and developmental disorders (PLoS One, Jangmo et al., Mar 2021).
  • Scottish school leavers who had been treated for ADHD were more likely to be unemployed after leaving school (adjusted odds ratio 1.39) (JAMA Pediatrics, Fleming et al., May 2017).
  • Among 414 Norwegian adults diagnosed with ADHD, 24% were in work, against 79% of a population control group, and stimulant treatment in childhood was the strongest predictor of being in work as an adult (odds ratio 3.2), an association in a cross-sectional clinic sample (Journal of Attention Disorders, Halmøy et al., Apr 2009).
  • In a later Oslo clinic sample of 813 adults with ADHD, 55.3% of women and 63.7% of men were working, and work was tied more to social factors and a history of depression than to IQ or symptom severity (Attention Deficit and Hyperactivity Disorders, Anker et al., Sep 2018).
  • In US national survey data from 2013 to 2019, adults with ADHD on stimulants showed no significant difference in employment outcomes from those not on stimulants (Journal of Attention Disorders, Pathan et al., Mar 2026).
  • For context, BLS does not track ADHD separately, but 22.8% of Americans with a disability were employed in 2025, against 65.2% of people without one, and their unemployment rate was 8.3%, double the 4.1% for everyone else (U.S. Bureau of Labor Statistics, Mar 2026).

What does ADHD cost the US economy?

The estimates run into the hundreds of billions of dollars a year, and most of the cost is lost work and income among adults; medical care is a small share. The two main US estimates use different methods, and one was funded by a drug maker, so they are listed side by side and never averaged.

What accommodations and assistive tools help people with ADHD?

Most workplace accommodations cost an employer nothing. Support most often breaks down at the move to college or work, because students and employees then have to ask for help themselves. The research on speech-to-text for writing difficulties is real but small, and it shows longer, faster writing more often than better grades.

Stacked bar chart of US college students with disabilities by main type of disability: the total rose from 2.3 million in 2004 to 3.5 million in 2020, and behavioral or emotional conditions, which include attention deficit disorder, grew from 33% to 69% of the total
Figure 6: Students with behavioral or emotional conditions, the group that includes ADD, drove nearly all the growth in US college students with disabilities from 2004 to 2020, and they are the students who have to request accommodations on their own. Source: US Government Accountability Office (GAO), Higher Education: Education Could Improve Information on Accommodations for Students with Disabilities (GAO-24-105614), Apr 2024. Chart published by the source, captured 2 Oct 2026.

How common and costly are workplace accommodations?

Most cost nothing, and most of the rest are a one-time expense of a few hundred dollars. The US figures below come from employers accommodating any disability, not ADHD alone.

  • 61% of employers said the accommodation their employee needed cost nothing, in a Job Accommodation Network survey of employers who implemented accommodations for any disability, 2019 to 2024 (Job Accommodation Network, Sep 2025).
  • 33% of employers reported a one-time accommodation expense, with a median cost of $300 (Job Accommodation Network, Sep 2025).
  • Only 6% of employers reported an ongoing accommodation cost, with a median of $2,400 a year (Job Accommodation Network, Sep 2025).
  • 66% of employers rated their accommodations very or extremely effective at helping workers with disabilities do their jobs, and 12% rated them ineffective (Job Accommodation Network, Sep 2025).
  • 85% of employers said an accommodation helped them keep the employee, 52% said it raised the employee's productivity and 48% said it removed the cost of training a replacement (Job Accommodation Network, Sep 2025).
  • The EEOC received 36,256 disability discrimination charges under the ADA in fiscal 2025, up from 22,843 in fiscal 2021, a 59% rise across all disabilities (EEOC, Table E6a ADA Charge Receipts FY 1992 - FY 2025, Mar 2026).

UK data names neurodivergence more directly, though still not ADHD alone.

How many college students use disability accommodations?

College support starts only when a student asks for it, and most students with disabilities never do.

Does speech-to-text help with writing difficulties?

Small studies suggest it often helps students produce more text. The evidence is thin, comes mostly from dyslexia and learning-disability research rather than ADHD, and the one sizable controlled trial found no difference between groups.

  • Speech input was 2.93 times faster than typing in English (153 vs 52 words per minute) in a Stanford and Baidu lab test on a smartphone, and 2.87 times faster in Mandarin (ACM IMWUT, Ruan et al., Dec 2017).
  • Speech made fewer errors during entry than typing (5.30% vs 11.22% corrected error rate) but left slightly more in the final text (1.30% vs 0.79%) (ACM IMWUT, Ruan et al., Dec 2017).
  • A scoping review of 22 years of research found only 8 peer-reviewed studies and 5 grey-literature reports on speech-to-text for secondary students with learning difficulties, and only 2 used experimental designs (Disability and Rehabilitation: Assistive Technology, Matre and Cameron, Apr 2024).
  • In a trial of 149 Swedish students with severe reading and writing difficulties, 24 sessions of assistive technology training, including speech-to-text, produced no difference in gains versus usual teaching, though the authors reported higher motivation for schoolwork (Disability and Rehabilitation: Assistive Technology, Svensson et al., Feb 2021).
  • In a Nordic single-case study, 7 of 8 middle-school students with writing difficulties wrote more after speech-to-text training, while word-level accuracy held or improved (Disability and Rehabilitation: Assistive Technology, Almgren Bäck et al., Nov 2024).
  • Four students with severe dyslexia made no conventional spelling errors when writing with speech-to-text, but misrecognized and dropped words added a correction step to their writing (Dyslexia, Svendsen et al., Feb 2026).

None of these studies tested ADHD specifically, and none tested a commercial app. What they show is narrower: speaking gets words down faster than typing, and students who struggle to write often produce more when they can talk first and edit after.

Methodology and Sources

These ADHD statistics for 2026 were traced to the organization that produced the data: federal agencies (CDC, NCHS, FDA, DEA, NCES, the US Department of Education, GAO, BLS, EEOC), UK government bodies (NHS England, DWP), peer-reviewed journals, and research groups only when they ran the study themselves (Truveta Research, JAN, CIPD). We do not cite statistics roundups, advocacy summaries or news coverage. Each link was opened on 2 October 2026 to confirm the page loads, the number appears on it and the date is right; numbers inside PDFs and data files were read from the file itself. Survey diagnoses, clinical interviews, health records and global models are labelled as such and never combined, industry funding is named in the sentence, and older studies are kept only where they remain the best evidence and are dated so readers can judge them. The page is refreshed monthly, starting with the FDA shortage listings and new CDC survey releases.

Glossary

  • ADA: Americans with Disabilities Act, the US law that requires reasonable accommodations at work.
  • ADD: attention deficit disorder, the older name still used in some federal surveys.
  • ADHD: attention-deficit/hyperactivity disorder.
  • APQ: aggregate production quota, the yearly limit the DEA sets on how much of a controlled substance can be made.
  • CDC: US Centers for Disease Control and Prevention.
  • CIPD: Chartered Institute of Personnel and Development, the UK professional body for HR.
  • CRDC: Civil Rights Data Collection, run by the US Department of Education's Office for Civil Rights.
  • DEA: US Drug Enforcement Administration.
  • DWP: Department for Work and Pensions (UK), which runs Access to Work.
  • EEOC: US Equal Employment Opportunity Commission.
  • FDA: US Food and Drug Administration.
  • GAO: US Government Accountability Office.
  • GBD: Global Burden of Disease study.
  • IDEA: Individuals with Disabilities Education Act, the US special education law.
  • JAN: Job Accommodation Network, funded by the US Department of Labor.
  • MMWR: Morbidity and Mortality Weekly Report, CDC's weekly journal.
  • NCES: National Center for Education Statistics.
  • NCHS: National Center for Health Statistics, part of CDC.
  • NCS-R: National Comorbidity Survey Replication, a US clinical interview survey of adults (2001-2003).
  • NCSER: National Center for Special Education Research, part of the Institute of Education Sciences.
  • NHIS: National Health Interview Survey, run by NCHS.
  • NLTS2: National Longitudinal Transition Study-2, which followed US students with disabilities into adulthood.
  • NSCH: National Survey of Children's Health, a parent survey run by HRSA.
  • OHI: other health impairment, the IDEA category that includes ADHD.
  • Presenteeism: being at work but getting less done, or doing it less well.
  • Section 504: the part of the Rehabilitation Act that gives US students with disabilities accommodations without special education.
  • WHO: World Health Organization.

Sources

Cite this page

Every figure here links to the study that produced it. Quote any of them with a link to this page or the original source.

WriteVoice. "167 ADHD Statistics October 2026." WriteVoice, October 2026. https://www.writevoice.io/statistics/adhd-statistics/
<a href="https://www.writevoice.io/statistics/adhd-statistics/">ADHD Statistics</a> (WriteVoice, October 2026)
  • Dyslexia Statistics How common dyslexia is in the US, UK and worldwide, reading and writing scores, special education, adult outcomes and the evidence on assistive technology.